Angiopoietin 1

From WikiMD's WELLNESSPEDIA

Angiopoietin 1 (also known as ANG-1) is a type of protein that in humans is encoded by the ANGPT1 gene. It is a vital component of the angiopoietin-Tie2 signaling pathway, which is critical for the development and maturation of blood vessels.

Function[edit]

ANG-1 is a secreted glycoprotein that plays a crucial role in the formation of blood vessels. It binds with the receptor tyrosine kinase Tie2, activating a signaling pathway that promotes angiogenesis, the process by which new blood vessels form from pre-existing ones. This interaction is essential for the stability and maturation of the vascular network.

Clinical Significance[edit]

Alterations in the ANG-1/Tie2 pathway have been associated with various pathological conditions. For instance, reduced levels of ANG-1 and increased levels of its antagonist, angiopoietin 2 (ANG-2), have been observed in patients with sepsis and acute lung injury. Moreover, ANG-1 has been implicated in the pathogenesis of cancer, as it can promote tumor angiogenesis and growth.

Research[edit]

Research into the role of ANG-1 in health and disease is ongoing. Studies are investigating its potential as a therapeutic target in conditions such as cancer, cardiovascular disease, and sepsis. For example, drugs that mimic the action of ANG-1 or enhance its activity could potentially be used to stimulate angiogenesis in patients with cardiovascular disease or to inhibit tumor growth in cancer patients.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.